Ki-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Kwan Il | - |
dc.contributor.author | Lee, Kyung Hee | - |
dc.contributor.author | Kim, Tae Ryung | - |
dc.contributor.author | Chun, Yong Soon | - |
dc.contributor.author | Lee, Tae Hoon | - |
dc.contributor.author | Park, Heung Kyu | - |
dc.date.available | 2020-02-28T17:47:20Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2014-03 | - |
dc.identifier.issn | 1738-6756 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/12820 | - |
dc.description.abstract | Purpose: The objectives of this study were to assess the potential value of Ki-67 in predicting response to neoadjuvant chemotherapy in breast cancer patients and to suggest a reasonable cutoff value for classifying Ki-67 expression. Methods: This study included 74 breast cancer patients who underwent surgery after anthracycline-based neoadjuvant chemotherapy between 2007 and 2012. We analyzed the clinical and immunohistochemical characteristics using core biopsy specimens obtained before neoadjuvant chemotherapy to determine their correlations with the response to chemotherapy. Results: A clinical complete response was observed in 6 patients (8.1%); a clinical partial response, in 44 patients (59.5%); and clinical stable disease, in 24 patients (32.4%). A pathologic complete response (pCR) was observed in 10 patients (13.5%). In univariate analysis, estrogen receptor (ER) negativity (p=0.031), human epidermal growth factor receptor 2 (HER2) positivity (p=0.040), and high Ki-67 expression (p=0.036) were predictive factors for a pCR. In multivariate analysis, Ki-67 was the only independent predictor of a pCR (p=0.049). The analysis of Ki-67 values revealed that 25% was a reasonable cutoff value for predicting the response to chemotherapy. In subgroup analysis, a higher Ki-67 value (>= 5%) was a significant predictive factor for the response to neoadjuvant chemotherapy, especially in ER-negative and HER2-positive breast cancer patients. Conclusion: Ki-67 expression in breast cancer tissue may be an effective factor for predicting the response to neoadjuvant chemotherapy. We suggest that a 25% level of Ki-67 expression is a reasonable cutoff value for predicting a response to chemotherapy. Moreover, Ki-67 is a useful predictive factor for pCR, especially in patients with ER-negative and HER2-positive breast cancer. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN BREAST CANCER SOC | - |
dc.relation.isPartOf | JOURNAL OF BREAST CANCER | - |
dc.subject | KI67 | - |
dc.subject | CHEMOSENSITIVITY | - |
dc.subject | INFORMATION | - |
dc.subject | EXPRESSION | - |
dc.subject | PROGNOSIS | - |
dc.subject | MARKER | - |
dc.subject | TUMORS | - |
dc.title | Ki-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000334012300006 | - |
dc.identifier.doi | 10.4048/jbc.2014.17.1.40 | - |
dc.identifier.bibliographicCitation | JOURNAL OF BREAST CANCER, v.17, no.1, pp.40 - 46 | - |
dc.identifier.kciid | ART001864036 | - |
dc.identifier.scopusid | 2-s2.0-84898471948 | - |
dc.citation.endPage | 46 | - |
dc.citation.startPage | 40 | - |
dc.citation.title | JOURNAL OF BREAST CANCER | - |
dc.citation.volume | 17 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Kim, Kwan Il | - |
dc.contributor.affiliatedAuthor | Lee, Kyung Hee | - |
dc.contributor.affiliatedAuthor | Kim, Tae Ryung | - |
dc.contributor.affiliatedAuthor | Chun, Yong Soon | - |
dc.contributor.affiliatedAuthor | Lee, Tae Hoon | - |
dc.contributor.affiliatedAuthor | Park, Heung Kyu | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Breast neoplasms | - |
dc.subject.keywordAuthor | Ki-67 antigen | - |
dc.subject.keywordAuthor | Neoadjuvant therapy | - |
dc.subject.keywordAuthor | Predictive value of tests | - |
dc.subject.keywordPlus | KI67 | - |
dc.subject.keywordPlus | CHEMOSENSITIVITY | - |
dc.subject.keywordPlus | INFORMATION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | PROGNOSIS | - |
dc.subject.keywordPlus | MARKER | - |
dc.subject.keywordPlus | TUMORS | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.